@rt.com 4 years ago
Cancer drugs in ‘two or three hundred consignments’ from Welsh supplier thrown out due to post-Brexit border delays, UK MPs told.
@TheNewEuropean 7 years ago
Failure to complete the first phase of Brexit negotiations is costing UK pharmaceutical companies "an enormous amount of money", industry representatives have warned theneweuropean.co.uk t.co
@nytimesworld 8 years ago
Britain’s pharmaceutical industry worries that Brexit may push EU drug agency out of London. nyti.ms t.co